Search results
The adoption of the USPSTF guidelines expands the recommended options for cervical cancer screening in average-risk individuals aged 30 years and older to include screening every 5 years with primary high-risk human papillomavirus (hrHPV) testing.
Guidelines Overview. Links and resources related to cervical screening, management, and colposcopy guidelines and recommendations. Screening Guidelines. Screening recommendations for the identification of precursors and prevention of cervical cancer. View Screening Guidelines. Management Guidelines & the Enduring Guidelines Process.
The new guidelines provide risk thresholds for clinical action (Table 1) and establish risk estimates for the development of cervical intraepithelial neoplasia grade 3 (CIN 3), adenocarcinoma in situ, or cancer (ie, CIN 3+) for different combinations of test results.
Cervical Cancer Screening Guidelines (2020) Created by the American Cancer Society. Access the full text of current ACS screening recommendations (and rationale) for prevention and early detection of cervical cancer.
30 lip 2020 · In this update of the ACS guideline for cervical cancer screening, we recommend that cervical cancer screening should begin in average-risk individuals with a cervix at age 25 years and cease at age 65 years and that the preferred strategy for regular screening is primary HPV testing every 5 years (Table 1).
2 kwi 2020 · New data indicate that a patient's risk of developing cervical precancer or cancer can be estimated using current screening test results and previous screening test and biopsy results, while considering personal factors such as age and immunosuppression.
In the “screen, triage and treat approach”, the decision to treat is based on a positive primary screening test followed by a positive second test (a “triage” test), with or without histologically confirmed diagnosis. Screen-and-treat approaches: 1.
